Side Effects of Weight Loss Medications: What to Expect

Most people starting a GLP-1 medication are prepared for it to work. Fewer are prepared for what working feels like.

I should say upfront: the side effect profile of these weight loss medications is real. They are not mild medications. They produce significant physiological effects, and that comes with real side effects that affect a meaningful portion of people who take them. At the same time, the serious side effects are rare, most of what comes up is manageable, and the experience typically improves substantially after the first two to three months. That's the frame.

Now let's get specific.

The First Month Is the Hardest

I tell every patient starting one of these weight loss medications: the first four to six weeks are usually the worst. Not to scare them. To prepare them. Because the patients who are caught off guard by month one are the ones who stop the medication, often just before they would have turned the corner.

The dominant symptom in month one is nausea. Something like 40 to 50 percent of people experience it. The severity ranges from mild, a persistent low-grade queasiness that makes eating feel like more of a chore, to significant enough to interfere with daily life. For the minority in that severe category, prescription anti-nausea medication is available and appropriate to use. For most, dietary adjustments are sufficient.

The biology: GLP-1 receptor activation slows gastric emptying. Your stomach holds food longer. This is central to how the medication works. But it also means that if you eat the way you used to, you're putting normal amounts of food into a stomach that is now moving at a slower pace, and you feel it.

The adjustment: eat less per sitting. I tell patients to aim for roughly 60 percent of their previous portion size from day one. Don't wait until you feel sick to figure out your new normal. And eat slowly. Your stomach's fullness signals travel to your brain on a slight delay under normal circumstances, and on these medications that delay is longer. If you eat at your old pace, you'll overshoot.

Beyond portion size, avoiding high-fat foods in the early weeks helps. Not because of a specific interaction, but because dietary fat slows gastric emptying further, stacking on top of what the drug is already doing.

Nausea almost always improves within a month. And when your dose goes up, it often returns briefly before settling again. This is normal. The dose escalation schedule exists specifically to give your body time to adapt before the next increase.

Constipation: The Sequel Nobody Warned Them About

Around weeks three to four, when nausea has often started to improve, a different complaint tends to emerge. Constipation. I see it in a large portion of my patients, and I think it is underrepresented in general patient education about these drugs.

The mechanism is the same as nausea. Slowed GI motility, this time in the intestines rather than just the stomach. Add to that the fact that patients are eating less, and sometimes drinking less than they used to without realizing it. Meals were accounting for more of their daily fluid intake than they knew. On weight loss medications, eating less means drinking less by default if they're not paying attention.

I had a patient recently who told me she had been constipated for three weeks and didn't mention it because she thought it was just how her body worked now. It's not. It's manageable.

Water is the first line. Genuinely tracking fluid intake, aiming for 60 to 80 ounces daily, makes a real difference. Fiber, added gradually. Sudden large increases can worsen constipation if water intake isn't keeping pace. Walking, even 20 to 30 minutes daily, has a meaningful effect on gut motility. Magnesium citrate or glycinate supplements work gently for most people. Miralax is fine to use periodically.

If constipation is severe, meaning five or more days without a bowel movement, or accompanied by significant abdominal pain or distension, that's a call to your doctor.

Hair Loss: The Most Misattributed Side Effect

Three to five months in, some patients notice hair shedding. More than usual in the shower. Visible thinning, especially at the temples or part line. And they look at their medication and think: this is what did it.

In most cases, the medication is not the direct cause. What's causing it is the caloric restriction and rapid weight loss from the past several months.

The condition is called telogen effluvium. When your body undergoes significant physiological stress, a larger than normal percentage of hair follicles shift into the resting phase of the hair growth cycle. Then, two to four months later, that resting hair sheds simultaneously. The delay is what makes it confusing. By month four, you've forgotten how drastically different your eating was in month one, and the timing with the medication makes it an easy target.

The hair loss is almost always temporary. Follicles rest, then return to active growth. Most patients see regrowth beginning around six months after the stressor that triggered it, with significant recovery by 12 months.

What you can do about it: protein intake, primarily. Hair follicles are protein-dependent structures. When caloric intake drops and protein isn't prioritized, follicle cycling is affected. Aiming for 0.7 to 1 gram of protein per pound of body weight is a target I give to essentially every patient on these medications, for both lean mass preservation and hair health. It's not a miracle fix, but it's the most evidence-adjacent thing available.

Fatigue: Your Body Recalibrating

Some patients come in around month two worried that something is wrong because they're tired. They're eating less, losing weight, things should feel good. Instead they feel sluggish.

This is normal, and it typically resolves by month three or four. Your body is adapting to running on significantly fewer calories than it's accustomed to. That's metabolically demanding work. The tiredness is part of the transition.

What makes it worse: inadequate protein, loss of muscle mass, insufficient sleep, and not exercising. I know that last one sounds counterintuitive when you're tired. But patients who maintain any level of resistance exercise during their weight loss medication consistently report better energy than those who become sedentary, even controlling for weight loss.

Fatigue that develops late in treatment, rather than in those first months, is worth a blood draw. Thyroid function, iron stores, and basic metabolic markers can develop issues independently and shouldn't be assumed to be medication-related.

Mood and Mental Health: The Question I Take Seriously

I want to spend a minute on this because I think it's easy to dismiss and shouldn't be.

Some patients feel better mentally on weight loss medications. Weight loss has genuine positive effects on mood and self-image. And the quieting of food preoccupation, what researchers sometimes call food noise, is something many patients describe as a kind of relief. The constant background anxiety around eating and hunger and craving just turns down. For people who have spent years fighting their relationship with food, this can be meaningful.

But some patients feel worse. Flatter. Less engaged. Occasionally frankly low. The FDA has added psychiatric monitoring language to the prescribing guidance for these drugs. The causal relationship is not firmly established in the data. But the mechanism is plausible. GLP-1 receptors are present in brain regions involved in reward and motivation, and a drug that changes how those circuits respond to food stimuli might affect other reward responses too.

My practice: I ask every patient with a mood history about this explicitly. I tell patients without a history to watch for it. And when patients raise it, I take it seriously rather than attributing everything to adjustment. If something feels off in a persistent way, it's worth discussing, regardless of whether the drug is the root cause.

The Red Flags: When to Stop Waiting

I want to be direct about the things that shouldn't be managed at home.

Severe abdominal pain radiating to the back. Upper abdominal, intense, accompanied by nausea and vomiting that feels distinctly different from your typical GLP-1 nausea. This describes pancreatitis. The incidence is low, but the stakes are high. Go to the emergency department. This is not a wait-and-see situation.

Right upper abdominal pain, especially after fatty meals, possibly with fever. This is the gallbladder pattern. GLP-1s are associated with increased gallstone risk, a combination of the drug's effects on gallbladder motility and the increased cholesterol saturation in bile that accompanies rapid weight loss. This needs evaluation.

Inability to stay hydrated. Nausea or vomiting severe enough that you can't keep fluids down for 24 hours is a medical situation. Significant dehydration can have downstream kidney effects and needs to be addressed, sometimes with IV fluids.

Spreading redness, warmth, or pus at an injection site. A small reaction is normal. A site that is getting worse over 48 hours, expanding, hot to the touch, or draining, needs to be looked at.

Persistent significant mood changes. Not just a rough week. A real shift that doesn't resolve over time.

Thyroid: What the Warning Actually Means

Patients see the FDA black box warning about thyroid cancer and want to know if they should be scared. Here's what I tell them.

The warning comes from animal studies, specifically rodents, that showed increased thyroid C-cell tumors at GLP-1 doses much higher than those used in human treatment. Those findings in rodents did not replicate in human clinical trials. Multiple large trials over multiple years have not found a statistically significant increase in medullary thyroid carcinoma in humans taking these drugs.

The contraindication is firm: if you have a personal or family history of medullary thyroid carcinoma or MEN2 (multiple endocrine neoplasia type 2), these medications are not appropriate for you. That's a clear line.

For everyone else, the risk in humans has not been established in the available evidence. Discuss it with your prescribing doctor in the context of your own history and risk factors. But the black box warning, without that context, can be more alarming than the human data warrants.

What Good Management Looks Like

In my experience, patients who do well on weight loss medications have a few things in common. They don't fight the drug's effects. They eat smaller portions, eat slowly, stay hydrated, move more than they think they have to. They reach out when something comes up rather than white-knuckling through it. And they give the medication time to work, understanding that the early months are the hard part and not representative of the long-term experience.

The patients who struggle tend to eat the same way they always have and then feel sick. They don't drink enough water. They don't reach out when constipation or nausea becomes a real quality of life issue because they assume it's supposed to be this way. It doesn't have to be.

Side effects on GLP-1 medications are real. Most are GI-related. Most are manageable. Most improve substantially by month three. The serious ones are rare but worth knowing about. And none of them have to be navigated alone.

That's the conversation I try to have before my patients start. It doesn't eliminate side effects, but it makes them easier to get through. And getting through them, for most people, is worth it.